Catalyst Wire Dossier Catalyst Wire Dossier

Rituxan (rituximab)

rituximab · Genentech
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Rituxan (rituximab), covering 2012-06-29 to 2026-03-31. Get the full timeline:

Most recent: Clinical Trial Update: Zanubrutinib, Bendamustine, Rituximab Prev. Untreated WM [Phase 2]

See pricing